SNTI - Senti Biosciences Inc.
3.21
-0.130 -4.050%
Share volume: 20,000
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.34
-0.13
-0.04%
Summary score
15%
Profitability
0%
Dept financing
12%
Liquidity
75%
Performance
16%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.68%
Return on assets
-18.93%
Return on sales
-3006%
Return on invested capital
-34.94%
Total debt ratio
43.51%
Debt ratio change over timeo
-2.3%
Current Ratio
5.58%
Quick Ratio
6.31%
Cash Position Ratio
3.67%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-21.69%
Return on assets
-20.26%
Return on sales
-3737.85%
Return on invested capital
-36.8%
Total debt ratio
46.13%
Debt ratio change over timeo
-2.33%
Current Ratio
5.45%
Quick Ratio
6.33%
Cash Position Ratio
3.22%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-21.59%
Return on assets
-15.95%
Return on sales
0%
Return on invested capital
-32.81%
Total debt ratio
45.11%
Debt ratio change over time
-1.86%
Current Ratio
5.79%
Quick Ratio
5.79%
Cash Position Ratio
2.47%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-38.26%
Return on assets
-43.03%
Return on sales
10331.29%
Return on invested capital
5.8%
Total debt ratio
-230.04%
Debt ratio change over time
-2.3%
Current Ratio
-18.19%
Quick Ratio
-20.45%
Cash Position Ratio
-12.57%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SNTI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -20.68% | 18.15% | 2.92% | 4.58% |
| Return on assets | -18.93% | 3.24% | 3.24% | 2.5% |
| Return on sales | -3006% | 32.46% | 30.87% | 24.31% |
| Return on invested capital | -34.94% | 5.53% | 1.1% | 4.42% |
| Profitability | 0% | 100% | 58% | 64% |
| Total debt ratio | 43.51% | 90.54% | 68.15% | 49.25% |
| Debt ratio change over time | -2.3% | 17.23% | 106.35% | 3.43% |
| Dept financing | 12% | 29% | 44% | 14% |
| Current Ratio | 5.45% | 2.18% | 1.19% | 2.26% |
| Quick Ratio | 6.33% | 1.79% | 1.05% | 1.63% |
| Cash Position Ratio | 3.22% | 1.28% | 0.5% | 0.61% |
| Liquididy | 75% | 21% | 17% | 24% |
| Short-term ratios | SNTI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -21.69% | 0% | -0.7% | 1.97% |
| Return on assets | -20.26% | 2.04% | 1.42% | 1.68% |
| Return on sales | -3737.85% | 24.13% | 12.88% | 18.45% |
| Return on invested capital | -36.8% | 0% | -0.19% | 2.14% |
| Profitability | 0% | 50% | 31% | 90% |
| Total debt ratio | 46.13% | 93.05% | 66.24% | 44.68% |
| Debt ratio change over time | -2.33% | 0% | 11.15% | -12.97% |
| Dept financing | 12% | 25% | 43% | 12% |
| Current Ratio | 5.45% | 2.18% | 1.19% | 2.26% |
| Quick Ratio | 6.33% | 1.79% | 1.05% | 1.63% |
| Cash Position Ratio | 3.22% | 1.28% | 0.5% | 0.61% |
| Liquididy | 75% | 27% | 13% | 22% |